ArticleNPJ digital medicine2026
Boosting foundation models for rare eye disease diagnosis via a multimodal text-to-image generative framework.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The rising prevalence of vision-threatening retinal diseases poses a significant burden on the global healthcare systems. Though deep learning (DL) techniques offer promising avenues for improving diagnostic efficiency, data scarcity and imbalance issues persist in training robust diagnostic models, particularly for rare eye diseases. Here, we introduce EyeDiff, a generative foundation model capable of synthesizing lesion-preserving ophthalmic images from textual descriptions. Both objective metrics and expert human evaluations confirmed EyeDiff's ability to generate high-fidelity images across multiple imaging modalities, accurately reflecting textual descriptions of diverse retinal diseases and lesion types. By augmenting minority classes across 11 globally sourced datasets, EyeDiff consistently boosted the diagnostic accuracy for both common and rare eye diseases across different foundation model types, including modality-specific, multimodal and vision-language foundation models trained solely on real data. These results underscore EyeDiff's potential as a general-purpose text-to-image foundation model, offering a scalable and flexible approach to generate balanced, disease-relevant data for advancing retinal disease diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.